Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Decreased eNOS protein expression in involuting and propranolol-treated hemangiomas.

Dai Y, Hou F, Buckmiller L, Fan CY, Saad A, Suen J, Richter GT.

Arch Otolaryngol Head Neck Surg. 2012 Feb;138(2):177-82. doi: 10.1001/archoto.2011.1096.

PMID:
22351865
2.

Expression of β-Adrenergic Receptor Subtypes in Proliferative, Involuted, and Propranolol-Responsive Infantile Hemangiomas.

Phillips JD, Zhang H, Wei T, Richter GT.

JAMA Facial Plast Surg. 2017 Mar 1;19(2):102-107. doi: 10.1001/jamafacial.2016.1188.

PMID:
27737446
3.

[Influences of gonadotropin releasing hormone agonist treatment on nitric oxide synthase expression in women with endometriosis and infertility].

Wang JH, Zhou FZ, Dong MY, Yuan L.

Zhonghua Fu Chan Ke Za Zhi. 2005 Jun;40(6):383-7. Chinese.

PMID:
16008888
4.

Propranolol for infantile hemangiomas: early experience at a tertiary vascular anomalies center.

Buckmiller LM, Munson PD, Dyamenahalli U, Dai Y, Richter GT.

Laryngoscope. 2010 Apr;120(4):676-81. doi: 10.1002/lary.20807.

PMID:
20112413
5.

[The expression of CEACAM-1 and CXCL-14 in infantile hemangioma].

Xu GQ, Lü RR, Huo R, Guo X.

Zhonghua Zheng Xing Wai Ke Za Zhi. 2010 May;26(3):195-8. Chinese.

PMID:
20737948
6.

Expression of glucocorticoid receptor isoforms in cutaneous hemangiomas and vascular malformations.

Jiang XW, Wang GH, Li JH, Chen ZX, He F.

Chin Med J (Engl). 2005 Jun 20;118(12):977-81.

PMID:
15978204
7.

Oral propranolol therapy for infantile hemangiomas beyond the proliferation phase: a multicenter retrospective study.

Zvulunov A, McCuaig C, Frieden IJ, Mancini AJ, Puttgen KB, Dohil M, Fischer G, Powell J, Cohen B, Ben Amitai D.

Pediatr Dermatol. 2011 Mar-Apr;28(2):94-8. doi: 10.1111/j.1525-1470.2010.01379.x. Epub 2011 Mar 1.

PMID:
21362031
8.

[Propranolol for the treatment of severe hemangiomas of infancy: results from a series of 28 patients].

Bernabeu-Wittel J, Pereyra-Rodríguez JJ, Mantrana-Bermejo ME, Fernández-Pineda I, de Agustín JC, Conejo-Mir J.

Actas Dermosifiliogr. 2011 Sep;102(7):510-6. doi: 10.1016/j.ad.2011.02.009. Epub 2011 Apr 22. Spanish.

PMID:
21514550
9.

Infantile hemangioma is a proliferation of LYVE-1-negative blood endothelial cells without lymphatic competence.

Nguyen VA, Kutzner H, Fürhapter C, Tzankov A, Sepp N.

Mod Pathol. 2006 Feb;19(2):291-8.

10.

Propofol protects against high glucose-induced endothelial dysfunction in human umbilical vein endothelial cells.

Zhu M, Chen J, Tan Z, Wang J.

Anesth Analg. 2012 Feb;114(2):303-9. doi: 10.1213/ANE.0b013e31823f0c42. Epub 2011 Dec 9.

PMID:
22156331
11.

[Evaluation of the role of serum vascular endothelial growth factor and urinary basic fibroblast growth factor in differential diagnosis of vascular anomalies].

Zhang L, Chen Q, Li D, Li XW, Wang HG, Li GZ.

Zhonghua Yi Xue Za Zhi. 2011 Apr 26;91(16):1092-5. Chinese.

PMID:
21609589
12.

Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas.

Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D.

JAMA Otolaryngol Head Neck Surg. 2013 Oct;139(10):1026-31. doi: 10.1001/jamaoto.2013.4773.

PMID:
24135743
13.

Propranolol given orally for proliferating infantile haemangiomas: analysis of efficacy and serological changes in vascular endothelial growth factor and endothelial nitric oxide synthase in 35 patients.

Yuan WL, Jin ZL, Wei JJ, Liu ZY, Xue L, Wang XK.

Br J Oral Maxillofac Surg. 2013 Oct;51(7):656-61. doi: 10.1016/j.bjoms.2012.12.003. Epub 2013 Jan 3.

PMID:
23291092
14.

Propranolol as the first-line therapy for infantile hemangiomas: preliminary results of two centers.

Celik A, Tiryaki S, Musayev A, Kismali E, Levent E, Ergun O.

J Drugs Dermatol. 2012 Jul;11(7):808-11.

PMID:
22777220
15.

Enhanced expression of endothelial nitric oxide synthase and caveolin-1 in human cirrhosis.

Yokomori H, Oda M, Ogi M, Sakai K, Ishii H.

Liver. 2002 Apr;22(2):150-8.

PMID:
12028410
16.

Treatment of hemangioma by transfection of antisense VEGF gene.

Shan S, Shan G, Zhang D.

J Huazhong Univ Sci Technolog Med Sci. 2009 Jun;29(3):335-9. doi: 10.1007/s11596-009-0314-y. Epub 2009 Jun 10.

PMID:
19513617
17.

Propranolol reduces infantile hemangioma volume and vessel density.

Bingham MM, Saltzman B, Vo NJ, Perkins JA.

Otolaryngol Head Neck Surg. 2012 Aug;147(2):338-44. doi: 10.1177/0194599812451570. Epub 2012 Jun 12.

PMID:
22691693
18.

[Treatment of infantile hemangiomas with low-dose propranolol: evaluation of short-term efficacy and safety].

Qin ZP, Liu XJ, Li KL, Zhou Q, Yang XJ, Zheng JW.

Zhonghua Yi Xue Za Zhi. 2009 Dec 1;89(44):3130-4. Chinese.

PMID:
20193276
19.

Cellular and extracellular markers of hemangioma.

Tan ST, Velickovic M, Ruger BM, Davis PF.

Plast Reconstr Surg. 2000 Sep;106(3):529-38.

PMID:
10987458
20.

Endothelial nitric oxide synthase (eNOS) expression and localization in healthy and diabetic rat hearts.

Felaco M, Grilli A, De Lutiis MA, Patruno A, Libertini N, Taccardi AA, Di Napoli P, Di Giulio C, Barbacane R, Conti P.

Ann Clin Lab Sci. 2001 Apr;31(2):179-86.

PMID:
11337908

Supplemental Content

Support Center